TRUQAP 200 mg/1 (Capivasertib TABLET, FILM COATED) 200 mg/1

TRUQAP 200 mg is a film-coated tablet containing capivasertib, used for targeted therapy. This medication is designed to interact with specific proteins in the body, supporting cancer treatment protocols.

Strength

200 mg/1

Pack Size

64 TABLET, FILM COATED in 1 BOTTLE (0310-9501-01)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRUQAP 200 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins involved in cell growth and division, which can help slow or stop the progression of cancer cells. Patients often wonder, 'What is TRUQAP used for?' This medication is typically prescribed as part of a broader treatment plan, including other therapies.

Side Effects

Common effects of TRUQAP 200 mg may include fatigue, nausea, and diarrhea. Some users also report changes in appetite or skin reactions. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

TRUQAP 200 mg should be handled with care, following the guidance of a healthcare professional. It is important to store the medication properly and to adhere to the prescribed dosage. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

Avoid Interactions

TRUQAP 200 mg may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of TRUQAP.

Frequently Asked Questions

TRUQAP 200 mg is used in the treatment of certain types of cancer, targeting specific proteins involved in cell growth.

TRUQAP 200 mg is taken orally, typically as prescribed by a healthcare professional. Always follow the guidance provided.

Common side effects may include fatigue, nausea, diarrhea, and changes in appetite. Severe or persistent symptoms should be reported to a healthcare provider.

Yes, TRUQAP may interact with other medications, especially those metabolized by the liver. Always inform your healthcare provider about all medications you are taking.

TRUQAP should be stored according to the instructions provided by the manufacturer, typically at room temperature and away from moisture.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.